We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

V:NYSEVisa Inc. Analysis

Data as of 2026-05-27 - not real-time

$326.48

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Visa delivers exceptional profitability with a net profit margin above 51%, an operating margin of 67% and a staggering ROE of 60%, underscoring its high‑margin, cash‑rich business model. Revenue is expanding at a robust 17% year‑over‑year, and free cash flow exceeds $20 bn, supporting a low 22% payout ratio and a sustainable dividend yield of roughly 0.8%. However, the current market price of $326.48 sits well above the DCF‑derived fair value of $283.8 and reflects a PE multiple of 28.5 versus an industry average of 16.7, suggesting the stock is priced on optimism rather than fundamentals.
On the technical front, the share trades just above its 20‑day SMA (≈$325) but below the 200‑day SMA (≈$331), with a neutral RSI near 55 and a bearish MACD histogram indicating short‑term momentum weakness. Volume trends are declining and 30‑day volatility remains high at nearly 28%, though the beta of 0.6 points to lower systematic risk. Recent analyst upgrades and upbeat earnings commentary provide positive sentiment, yet Berkshire Hathaway’s complete exit from Visa adds a note of caution. Overall, the combination of strong fundamentals, modest dividend sustainability, and mixed technical signals frames a nuanced investment outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD crossover and decreasing volume
  • Price trading near resistance with limited upside
  • High valuation relative to DCF and industry peers

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong earnings growth and expanding margins
  • Analyst price targets averaging ~$400 indicating ~20% upside
  • Sustainable dividend and robust free cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Durable network moat and global payment volume expansion
  • Exceptional ROE and cash generation supporting reinvestment
  • Low beta and defensive sector positioning mitigating market swings

Key Metrics & Analysis

Financial Health

Revenue Growth17.10%
Profit Margin51.68%
P/E Ratio28.5
ROE60.35%
ROA19.19%
Debt/Equity67.23
P/B Ratio16.3
Op. Cash Flow$22.8B
Free Cash Flow$20.8B
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI54.7
Support$308.74
Resistance$341.98
MA 20$325.42
MA 50$314.04
MA 200$330.93
MACDBearish
VolumeDecreasing
Fear & Greed Index91.05

Valuation

Fair Value$283.82
Target Price$398.74
Upside/Downside22.13%
GradeOvervalued
TypeBlend
Dividend Yield0.82%

Risk Assessment

Beta0.61
Volatility27.95%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.